title: Hemangiopericytoma in the central nervous system. A study of eight cases.
abstract: Most hemangiopericytomas (HPC) are located in the musculoskeletal system and the skin, while the location in the central nervous system (CNS) is rare. The latter represents 2 to 4% in large series of meningeal tumors, thus accounting for less than 1% of all CNS tumors. In the central nervous system, tumors with a hemangiopericytomatous histolopathological pattern can be either hemangiopericytomas or solitary fibrous tumors. CNS-HPCs have a relentless tendency for local recurrence and metastases outside the CNS. Metastasis can also appear many years after adequate treatment of the primary tumor. We present a pathological study of eight patients with CNS-HPC and compare our results with corresponding published data. The CNS-HPC group consisted of three males and five females with a mean age of 36.75 years. The tumors were supratentorial in four cases, infratentorial in two cases, tentorial in one case and located in the spinal cord in the last one. Histologically, CNS-HPCs were similar to their soft tissue counterparts. One case demonstrated increased cellularity, marked nuclear hyperchromasia and marked cellular pleomorphism with infiltration of the cerebellum. All patients underwent surgery with gross-total resection in all cases. No patients received postoperative radiation therapy. Only four patients recurred locally after six, seven and eight months, and five years. Our study presents the pathological features of CNS-HPC as a distinct entity from both meningioma and solitary fibrous tumors. A comparative review of literature with our results is discussed.
authors.affiliation: Department of Pathology, La Rabta Hospital, 1007 Bab-Saadoun, 7, rue Moncef-Bey, Menzeh-7, 2091 Tunis, Tunisia. aminamekninouira@yahoo.fr
authors.forename: A
authors.initials: A
authors.lastname: Mekni
authors.forename: J
authors.initials: J
authors.lastname: Kourda
authors.forename: I
authors.initials: I
authors.lastname: Chelly
authors.forename: L
authors.initials: L
authors.lastname: Ferchichi
authors.forename: K
authors.initials: K
authors.lastname: Bellil
authors.forename: K B
authors.initials: KB
authors.lastname: Hammouda
authors.forename: N
authors.initials: N
authors.lastname: Kchir
authors.forename: M
authors.initials: M
authors.lastname: Zitouna
authors.forename: M
authors.initials: M
authors.lastname: Khaldi
authors.forename: S
authors.initials: S
authors.lastname: Haouet
mesh_terms: D000328:Adult; D018952:Antigens, CD34 / Q000378:metabolism; D016543:Central Nervous System Neoplasms / Q000473:pathology / Q000601:surgery*; D005260:Female; D006393:Hemangiopericytoma / Q000473:pathology / Q000601:surgery*; D006801:Humans; D007150:Immunohistochemistry; D015192:Infratentorial Neoplasms / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009457:Neuroglia / Q000473:pathology; D019635:Neurosurgical Procedures; D013120:Spinal Cord Neoplasms / Q000473:pathology / Q000601:surgery; D015173:Supratentorial Neoplasms / Q000473:pathology / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D018952:Antigens, CD34